Heterogeneous metastasis efficiency of isogenic orthotopic colon cancer xenografts reveals distinctive gene expression profiles

Tumor Biology

Volumn 28, Issue 3, 2007, Pages 139-150

  Abal, Miguel ^a   Fsihi, Hafida ^a   Bras Gonçalves, Rui ^a   Doll, Andreas ^b   Boyé, Karine ^a   Janssen, Klaus Peter ^a   Alameda, Francesc ^c,d   Reventós, Jaume ^b,d   Louvard, Daniel ^a   Magdelenat, Henri ^a   Poupon, Marie France ^a   Robine, Sylvie ^a  

^a INSTITUT CURIE   (France)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Colorectal cancer; DCC; Dynamic heterogeneity; Gene expression; Metastasis; RhoC

Indexed keywords

CALVASCULIN; CAVEOLIN 1; COMPLEMENTARY DNA; PROTEIN S 100; TRANSCRIPTION FACTOR ETS 2;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 34250839347     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103009     Document Type: Article

References (42)

1. Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
2. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-458.
3. Weiss L: Random and nonrandom processes in metastasis, and metastatic inefficiency. Invasion Metastasis 1983;3:193-207.
4. Hill RP, Chambers AF, Ling V, Harris JF: Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 1984;224:998-1001.
5. Ling V, Chambers AF, Harris JF, Hill RP: Dynamic heterogeneity and metastasis. J Cell Physiol Suppl 1984;3:99-103.
6. Fukunari H, Iwama T, Sugihara K, Miyaki M: Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis. Surg Today 2003;33:408-413.
7. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
8. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
9. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
10. Woelfle U, Cloos J, Sauter G, Riethdorf L, Janicke F, van Diest P, Brakenhoff R, Pantel K: Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003;63:5679-5684.
11. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549.
12. Roepman P, de Koning E, van Leenen D, de Weger RA, Kummer JA, Slootweg PJ, Holstege FC: Dissection of a metastatic gene expression signature into distinct components. Genome Biol 2006;7:R117.
13. Tsukui H, Pocard M, Salmon RJ, Lefrancois D, Languille-Mimoune O, Dutrillaux B, Poupon MF: Orthotopic implantation of human colon cancers into nude mice. Methodology and physiopathological value. Gastroenterol Clin Biol 1994;18:1112-1118.
14. Traicoff JL, Willson JK, Markowitz SD: Early loss of deleted in colorectal carcinoma gene transcript detected in a group of benign colon adenomas. J Biomed Sci 2002;9:716-720.
15. Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T: Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst 1993;85:2023-2029.
16. Bras-Goncalves RA, Pocard M, Formento JL, Poirson-Bichat F, De Pinieux G, Pandrea I, Arvelo F, Ronco G, Villa P, Coquelle A, Milano G, Lesuffleur T, Dutrillaux B, Poupon MF: Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. Gastroenterology 2001;120:874-888.
17. Hoffman RM: Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem 1994;56:1-3.
18. Pocard M, Tsukui H, Salmon RJ, Dutrillaux B, Poupon MF: Efficiency of orthotopic xenograft models for human colon cancers. In Vivo 1996;10:463-469.
19. Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
20. Penna C, Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin North Am 2002;82:1075-1090, x-xi.
21. Salbe C, de Cremoux P, Bonneton C, Manet S, Almeida A, Magdelenat H, Bourstyn E, Robine S: Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastases. Int J Biol Markers 2000;15:41-43.
22. Ito H, Hatori M, Kinugasa Y, Irie T, Tachikawa T, Nagumo M: Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 2003;23:1425-1431.
23. Kitada T, Miyoshi E, Noda K, Higashiyama S, Ihara H, Matsuura N, Hayashi N, Kawata S, Matsuzawa Y, Taniguchi N: The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 2001;276:475-480.
24. Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-535.
25. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, Mak TW: RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005;19:1974-1979.
26. Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD: RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat 2005;93:101-110.
27. Fiordalisi JJ, Keller PJ, Cox AD: PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 2006;66:3153-3161.
28. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
29. Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993;4:219-229.
30. Bernards R, Weinberg RA: A progression puzzle. Nature 2002;418:823.
31. Yamasaki M, Takemasa I, Komori T, Watanabe S, Sekimoto M, Doki Y, Matsubara K, Monden M: The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 2007;30:129-138.
32. Koehler A, Bataille F, Schmid C, Ruemmele P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W: Gene expression profiling of colorectal caner and metastases divides tumours according to their clinicopathological stage. J Pathol 2004;204:65-74.
33. Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, Choi HJ, Jeong JS, Kim HJ, Hwang TH: Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 2004;47:141-152.
34. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003;9:2632-2641.
35. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glossl J, Mach L: Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999;83:526-531.
36. Hirai K, Yokoyama M, Asano G, Tanaka S: Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 1999;30:680-686.
37. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N: Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 1996;271:13811-13815.
38. Saito M, Yamaguchi A, Goi T, Tsuchiyama T, Nakagawara G, Urano T, Shiku H, Furukawa K: Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis. Oncology 1999;56:134-141.
39. Johnson JP: Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev 1991;10:11-22.
40. Schimmenti LA, Yan HC, Madri JA, Albelda SM: Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration. J Cell Physiol 1992;153:417-428.
41. Seifert M, Welter C, Mehraein Y, Seitz G: Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol 2005;205:623-632.
42. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y: Colorectal cancer: genetics of development and metastasis. J Gastroenterol 2006;41:185-192.